You are here

  • Home
  • Archive
  • Volume 1, Issue 5
  • The ‘failure free interval’ defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing

Article info

Article menu
Download PDFPDF
Original Article
The ‘failure free interval’ defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing

Authors

  1. Address for correspondence: P.J. Hoskins, B. C. Cancer Agency, Vancouver Clinic, 600 W.10th Avenue, Vancouver, B.C., Canada V5Z 4E6.

Citation

HOSKINS PJ, O'REILLY SE, SWENERTON KD
The ‘failure free interval’ defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing
International Journal of Gynecologic Cancer 1991;1:205-208.

Publication history

  • First published August 1, 1991.
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

1991 International Gynecological Cancer Society and the European Society of Gynaecological Oncology